Work

Sulindac, a COX1/COX2 inhibitor, exhibits anti-tumorigenic effects in obesity-driven models of endometrioid endometrial cancer (2289)

Year: 2023

Type: article

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2023.06.407

Authors: Catherine John, Ziyi Zhao, Xiaochang Shen, Boer Deng, Isabella Strauss, Chunxiao Zhou, Mark Sherman, Stephen Hursting, Victoria Bae-Jump

Institutions: University of North Carolina at Chapel Hill, Mayo Clinic in Florida

Language: English

Topic: Inflammatory mediators and NSAID effects

Subfield: Pharmacology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4387214946

FWCI:

Cites:

Cited by:

Related to: 10